Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

Abstract Background IgA nephropathy is the most common glomerular disease and is a common cause of progression to end-stage renal disease in patients with kidney diseases. Proteinuria levels are critical for the prognosis of patients with IgA nephropathy, but many patients are still unable to effect...

Full description

Bibliographic Details
Main Authors: Qi Chen, Zi Wang, Jicheng Lv, Lijun Liu, Hang Li, Weiwei Sun, Yanhong Huo, Yingbo Guo, Cun Shen, Shichao Li, Zhenjie Chen, Jingwei Zhou
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Trials
Subjects:
IgA nephropathy
Artesunate
Proteinuria
Online Access:https://doi.org/10.1186/s13063-022-06336-3

Internet

https://doi.org/10.1186/s13063-022-06336-3

Similar Items